JXSS1000004 | 注射用重组人凝血因子VIII | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Import Drug Application | 2010-06-21 | | Baxter SA;Baxter AG | Certificate Issued | 2012-05-10 | view |
JYSB1900083 | 注射用重组人凝血因子Ⅷ | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Supplementary Application | 2019-04-24 | | Wyeth Farma SA;Pfizer Ltd | Certificate Issued | 2019-10-30 | view |
JYSB2100026 | 注射用重组人凝血因子VIII | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Supplementary Application | 2021-01-22 | | Pfizer Europe Ma Eeig;Wyeth Farma SA | In Review | 2021-01-21 | view |
JXSL1600038 | 注射用重组人凝血因子VIII | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Import Drug Application | 2016-07-11 | | Bayer Pharma AG | Certificate Issued | 2018-07-27 | view |
JYSB0800073 | 注射用重组人凝血因子VIII | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Supplementary Application | 2008-06-28 | | Bayer Healthcare LLC | Certificate Issued | 2009-07-31 | view |
JYSB1800114 | 注射用重组人凝血因子Ⅷ | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Supplementary Application | 2018-05-17 | | Baxter AG;Baxalta Manufacturing Sàrl | Filed | 2018-05-30 | view |
JYSB2000404 | 注射用重组人凝血因子VIII | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Supplementary Application | 2020-08-21 | | Pfizer Europe Ma Eeig;Wyeth Farma SA | Filed | 2020-09-01 | view |
JYSB1500116 | 注射用重组人凝血因子VIII | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Supplementary Application | 2015-04-24 | | Wyeth Farma SA;Wyeth Pharmaceuticals Inc | Certificate Issued | 2015-10-29 | view |
JYSB2200092 | 注射用重组人凝血因子VIII | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Supplementary Application | 2022-06-09 | | Pfizer Europe Ma Eeig;Wyeth Farma SA | | | view |
JYSB1700078 | 注射用重组人凝血因子Ⅷ | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Supplementary Application | 2017-05-03 | | Bayer Healthcare LLC | Certificate Issued | 2018-06-15 | view |
JYSZ2200049 | 注射用重组人凝血因子Ⅷ | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | License Renew | 2022-09-14 | | Bayer Healthcare LLC;Bayer Healthcare Company Ltd | | | view |
JYSB2400158 | 注射用重组人凝血因子Ⅷ | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Supplementary Application | 2024-07-16 | | Pfizer Europe Ma Eeig;Wyeth Farma SA | | | view |
CYSB2200011 | 注射用重组人凝血因子Ⅷ | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products(原10) | Supplementary Application | 2022-01-10 | | SinoCelltech Ltd | | | view |
JYSB1800179 | 注射用重组人凝血因子VIII | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Supplementary Application | 2018-08-17 | | Wyeth Farma SA;Pfizer Ltd | Filed | 2018-08-23 | view |
JYSB2000558 | 注射用重组人凝血因子VIII | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Supplementary Application | 2020-11-04 | | Bayer Healthcare LLC | Filed | 2020-11-17 | view |
JYSB1500133 | 注射用重组人凝血因子Ⅷ | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Supplementary Application | 2015-05-19 | | Baxter AG;Baxter Bioscience Manufacturing Sarl | Certificate Issued | 2017-03-27 | view |
JYSB2200094 | 注射用重组人凝血因子VIII | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Supplementary Application | 2022-06-09 | | Pfizer Europe Ma Eeig;Wyeth Farma SA | | | view |
JYSB1800048 | 注射用重组人凝血因子Ⅷ | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Supplementary Application | 2018-03-23 | | Bayer Healthcare LLC | Certificate Issued | 2018-07-27 | view |
JYSB1400239 | 注射用重组人凝血因子VIII | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Supplementary Application | 2014-12-09 | | Wyeth Farma SA;Wyeth Pharmaceuticals Inc | Certificate Issued | 2015-06-19 | view |
JYSB2200063 | 注射用重组人凝血因子Ⅷ | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Supplementary Application | 2022-04-08 | | Novo Nordisk A/S | | | view |